newsfilter
← Latest News
GlobeNewswire·

Aridis Pharmaceuticals Announces $2.28 Million Registered Direct Offering of Common Stock

Los Gatos, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS), a biopharmaceutical company, today announced that it has entered into a definitive agreement for the issuance and sale